Stay informed with timely news, analysis, and insights on CTP reimbursement, legislation, and policy changes. Learn how evolving regulations may affect clinicians, providers, and patient access to care.
This speaker discusses the audit implications of inaccuracies in wound care documentation, highlighting the importance of maintaining documentation integrity at practices of any size.
This speaker discusses the audit implications of inaccuracies in wound care documentation, highlighting the importance of maintaining documentation integrity at practices of any size.
New 2026 CMS reimbursement changes for cellular and tissue-based products (CTPs) are poised to reshape wound care delivery. In this Q&A, Shital Sharma, DPM, MS, MBA, breaks down how cost containment efforts may...
New 2026 CMS reimbursement changes for cellular and tissue-based products (CTPs) are poised to reshape wound care delivery. In this Q&A, Shital Sharma, DPM, MS, MBA, breaks down how cost containment efforts may...
This author emphasizes that inconsistencies in measurement of wounds for CTPs can lead to red flags for auditors, as erratic size changes or consistent overestimations may suggest improper billing practices.
This author emphasizes that inconsistencies in measurement of wounds for CTPs can lead to red flags for auditors, as erratic size changes or consistent overestimations may suggest improper billing practices.
As CMS restructures reimbursement for skin substitutes and other cellular and tissue-based products (CTPs), uncertainty continues to ripple across the wound care landscape. In this interview, Rob Odell, Founder and CEO of Bobber Biotech,...
As CMS restructures reimbursement for skin substitutes and other cellular and tissue-based products (CTPs), uncertainty continues to ripple across the wound care landscape. In this interview, Rob Odell, Founder and CEO of Bobber Biotech,...
In the first of three videos, this speaker focuses on the critical role of measurement accuracy in wound care, emphasizing its impact on medical necessity and reimbursement processes.
In the first of three videos, this speaker focuses on the critical role of measurement accuracy in wound care, emphasizing its impact on medical necessity and reimbursement processes.
Under the Social Security Act, Medicare covers only items and services that are “reasonable and necessary for the diagnosis or treatment of illness or injury.” For skin substitutes, medical necessity is evaluated through statutory standards...
Under the Social Security Act, Medicare covers only items and services that are “reasonable and necessary for the diagnosis or treatment of illness or injury.” For skin substitutes, medical necessity is evaluated through statutory standards...
The CTP News Desk delivers fast, trusted news and expert insights on wound care reimbursement, policy, and legislative updates that impact clinicians, providers, and patients. We break down key topics such as CMS payment rules, the Clinical Trial Requirement Rule, coverage policies, and market trends—helping the wound care community understand how these changes affect the use of cellular and tissue-based products (CTPs) in clinical practice.
Through balanced reporting, stakeholder perspectives, and real-world analysis, we connect evolving reimbursement policy to its direct implications for patient care, clinical decision-making, and sustainable wound management programs.